Brief: Hester Biosciences Approves Divestment Of 43.81% Equity In Texas Lifesciences
11/03/2026 06:56
March 11 (Reuters) - Hester Biosciences Ltd HEST.NS: APPROVES DIVESTMENT OF 43.81% EQUITY IN TEXAS LIFESCIENCES CONSIDERATION FOR SALE IS 92 MILLION RUPEES Source text: ID:nBSEbjfJjj Further company coverage: HEST.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Hester Biosciences
See all newsIndia's Hester Biosciences jumps on quarterly profit rise
Brief: Hester Biosciences March-Quarter Consol Net Profit 159.8 Million Rupees
India's Hester Biosciences gains on plan to sell stake in Texas Lifesciences
Brief: Hester Biosciences Approves Divestment Of 43.81% Equity In Texas Lifesciences
Brief: Hester Biosciences Re-Appoints Rajiv Gandhi As CEO & MD